Health Care & Life Sciences » Pharmaceuticals | Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Inc. | Ownership

Companies that own Spring Bank Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BVF Partners LP
785,950
5.96%
-46,297
0.75%
06/30/2018
BlackRock Fund Advisors
440,807
3.34%
412,488
0%
06/30/2018
Tiedemann Wealth Management LLC
412,049
3.13%
0
0.35%
06/30/2018
The Vanguard Group, Inc.
386,043
2.93%
27,744
0%
06/30/2018
Baker Bros. Advisors LP
373,144
2.83%
0
0.03%
06/30/2018
AXA Investment Managers UK Ltd.
370,621
2.81%
106,741
0.02%
06/30/2018
Parsons Capital Management, Inc.
281,213
2.13%
-410
0.42%
06/30/2018
Morse Asset Management, Inc.
177,500
1.35%
11,725
0.66%
06/30/2018
SSgA Funds Management, Inc.
148,232
1.12%
148,232
0%
06/30/2018
Sectoral Asset Management, Inc.
131,656
1%
0
0.19%
06/30/2018

About Spring Bank Pharmaceuticals

View Profile
Address
35 Parkwood Drive
Hopkinton Massachusetts 01748
United States
Employees -
Website http://www.springbankpharm.com
Updated 07/08/2019
Spring Bank Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its pipeline include RIG-I & STING Agonists platforms. The company was founded by Douglas J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.